• Hematoxylin and Eosin Staining Kit Guide

  2026-09-02

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for consistent tissue morphology visualization in paraffin-embedded, frozen, and cytological samples. It is intended for research workflows and morphological assessment only, not for diagnosis, clinical decisions, or regulated medical use.

• Hexose Diphosphate in Metabolic Assays

  2026-09-02

  Hexose diphosphate supports practical studies of glycolytic control, ischemic energy failure, and inflammation-linked metabolic remodeling. This workflow-focused guide explains how to prepare the water-soluble hexose phosphate, design interpretable cell and tissue assays, and distinguish its effects from the phosphoenolpyruvate mechanism reported in healthy-aging research.

• Cholecystokinin Octapeptide Ammonium: ANP Signaling

  2026-09-01

  Cholecystokinin octapeptide ammonium is a sulfated CCK-8 research reagent whose effects extend from GPCR activation to oxidative signaling and ANP release. This article focuses on the isolated-atria evidence and translates it into a causal, assay-design framework rather than a generic applications overview.

• Reactive Oxygen Species Assay Kit for OA Research

  2026-09-01

  Use the Reactive Oxygen Species Assay Kit to connect intracellular superoxide with cartilage senescence, matrix loss, and redox signaling. This DHE workflow combines live-cell measurement, positive-control validation, and pathway-level interpretation for osteoarthritis and related oxidative stress models.

• Reactive Oxygen Species Assay Kit for Superoxide

  2026-08-31

  A practical guide to using a dihydroethidium (DHE) probe for intracellular superoxide measurement in live-cell fibrosis and mitophagy experiments. The workflow connects red fluorescence with mitochondrial quality-control readouts while emphasizing controls, normalization, and troubleshooting.

• 28S rRNA Expansion Segments Build Nucleolar Layers

  2026-08-31

  Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that can reconstitute layered nucleolar-like organization. Comparative, deletion, transfer, and reconstitution experiments connect evolutionary expansion of these RNA regions with the emergence of more complex nucleolar architecture.

• Human ClpP Activators: Design, Mechanisms, and ZK53

  2026-08-30

  The 2025 Future Medicinal Chemistry review organizes recent small-molecule strategies for human mitochondrial ClpP, emphasizing activator design, structure–activity relationships, and pharmacological evaluation. Its analysis positions compounds such as imipridone derivatives and ZK53 as tools for perturbing mitochondrial proteostasis while identifying selectivity, pharmacokinetic, and safety challenges that remain before broader therapeutic translation.

• Melatonin Blocks Atrazine-Induced Renal Necroptosis

  2026-08-29

  The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced kidney injury and shows that melatonin limits this damage in cellular and animal models. Its combination of pathway perturbation, mitochondrial and inflammatory readouts, and computational binding analysis provides a mechanistic framework for studying chemical nephrotoxicity.

• Rucaparib (AG-014699) DNA Repair Workflows

  2026-08-28

  Rucaparib (AG-014699) enables controlled studies of PARP1 inhibition, persistent DNA damage, and cancer-cell radiosensitization. This workflow connects established prostate cancer assays with an emerging HCC strategy centered on SmD2-dependent splicing and BRCA1/FANC repair outputs.

• Gap19: Selective Cx43 Hemichannel Blocker

  2026-08-28

  Gap19 enables selective interrogation of Cx43 hemichannel signaling while preserving gap junction communication, making it useful for astrocyte ATP assays, macrophage inflammation studies, and ischemia models. This workflow-focused guide connects dose selection, pathway readouts, and troubleshooting to practical neuroglial and immune experiments.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor

  2026-08-27

  EPI-001 is an androgen receptor N-terminal domain inhibitor designed for studies of ligand-dependent and ligand-independent AR signaling, with particular value in CRPC and AR-positive TNBC models. This guide translates its mechanism into practical dose-response, transcriptional, migration, and troubleshooting workflows.

• Spirocyclic POM Analogues Target MmpL3 in TB

  2026-08-27

  The 2024 Bioorganic Chemistry study develops spirocyclic phenyl oxazole methyl derivatives as a new MmpL3-directed strategy against Mycobacterium tuberculosis. Compound 5c combined submicromolar activity with activity against drug-resistant clinical isolates, acceptable preliminary ADME and pharmacokinetic properties, and low cytotoxicity in THP-1 cells.

• Reactive Oxygen Species Assay Kit: From Signal to Mechanism

  2026-08-26

  The Reactive Oxygen Species Assay Kit provides a practical route to intracellular superoxide measurement with a dihydroethidium (DHE) probe. This guide connects DHE signal interpretation with TrxR/MAPK immunology, assay controls, and decisions in oxidative stress research.

• Anti Reverse Cap Analog for Synthetic mRNA

  2026-08-26

  Anti Reverse Cap Analog enables orientation-specific 5′ capping for synthetic mRNA workflows that demand strong translation and reproducibility. This guide connects ARCA optimization with practical reprogramming, gene-expression, and mRNA therapeutics research workflows, including controls and troubleshooting steps.

• Leucovorin Calcium in Tumor–Stroma Assays

  2026-08-25

  Leucovorin Calcium, also known as calcium folinate, can serve as more than a methotrexate rescue reagent. This article explains how paired organoid–assembloid assays use folate rescue to distinguish tumor-intrinsic sensitivity from stromal modulation.

7784 records 1/519 page Next 12345 下5页 Last page